A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Embecta Corp. stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 1 shares of EMBC stock, worth $14. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$14
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$15.0 - $22.17 $15 - $22
1 New
1 $0
Q3 2022

Nov 16, 2022

BUY
$24.0 - $33.42 $360 - $501
15 New
15 $0
Q3 2022

Nov 14, 2022

SELL
$24.0 - $33.42 $360 - $501
-15 Closed
0 $0
Q2 2022

Aug 12, 2022

BUY
$24.78 - $33.36 $371 - $500
15 New
15 $0

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $819M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Kayne Anderson Rudnick Investment Management LLC Portfolio

Follow Kayne Anderson Rudnick Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.